- Home
- RLYB vs DRCT Comparison
RLYB vs DRCT Comparison
Compare RLYB & DRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLYB
- DRCT
- Stock Information
- Founded
- RLYB 2018
- DRCT 2018
- Country
- RLYB United States
- DRCT United States
- Employees
- RLYB N/A
- DRCT N/A
- Industry
- RLYB Biotechnology: Pharmaceutical Preparations
- DRCT Computer Software: Programming Data Processing
- Sector
- RLYB Health Care
- DRCT Technology
- Exchange
- RLYB Nasdaq
- DRCT Nasdaq
- Market Cap
- RLYB 14.4M
- DRCT 16.7M
- IPO Year
- RLYB 2021
- DRCT 2022
- Fundamental
- Price
- RLYB $0.35
- DRCT $0.55
- Analyst Decision
- RLYB Hold
- DRCT Strong Buy
- Analyst Count
- RLYB 3
- DRCT 1
- Target Price
- RLYB $15.00
- DRCT $6.00
- AVG Volume (30 Days)
- RLYB 329.4K
- DRCT 157.6K
- Earning Date
- RLYB 08-07-2025
- DRCT 05-06-2025
- Dividend Yield
- RLYB N/A
- DRCT N/A
- EPS Growth
- RLYB N/A
- DRCT N/A
- EPS
- RLYB N/A
- DRCT N/A
- Revenue
- RLYB $848,000.00
- DRCT $48,170,000.00
- Revenue This Year
- RLYB N/A
- DRCT $50.71
- Revenue Next Year
- RLYB N/A
- DRCT $26.31
- P/E Ratio
- RLYB N/A
- DRCT N/A
- Revenue Growth
- RLYB N/A
- DRCT N/A
- 52 Week Low
- RLYB $0.22
- DRCT $0.44
- 52 Week High
- RLYB $1.54
- DRCT $6.59
- Technical
- Relative Strength Index (RSI)
- RLYB 53.64
- DRCT 51.91
- Support Level
- RLYB $0.30
- DRCT $0.51
- Resistance Level
- RLYB $0.38
- DRCT $0.56
- Average True Range (ATR)
- RLYB 0.04
- DRCT 0.03
- MACD
- RLYB 0.00
- DRCT 0.01
- Stochastic Oscillator
- RLYB 49.29
- DRCT 70.27
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.
About DRCT Direct Digital Holdings Inc.
Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform primarily focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.